JP2025502891A5 - - Google Patents
Info
- Publication number
- JP2025502891A5 JP2025502891A5 JP2024543040A JP2024543040A JP2025502891A5 JP 2025502891 A5 JP2025502891 A5 JP 2025502891A5 JP 2024543040 A JP2024543040 A JP 2024543040A JP 2024543040 A JP2024543040 A JP 2024543040A JP 2025502891 A5 JP2025502891 A5 JP 2025502891A5
- Authority
- JP
- Japan
- Prior art keywords
- product according
- pharmaceutical product
- satralizumab
- dose
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263300893P | 2022-01-19 | 2022-01-19 | |
| US63/300,893 | 2022-01-19 | ||
| PCT/JP2023/001270 WO2023140269A1 (en) | 2022-01-19 | 2023-01-18 | Treatment of autoimmune encephalitis with satralizumab |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502891A JP2025502891A (ja) | 2025-01-28 |
| JP2025502891A5 true JP2025502891A5 (https=) | 2026-01-14 |
Family
ID=87348849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543040A Pending JP2025502891A (ja) | 2022-01-19 | 2023-01-18 | 自己免疫性脳炎のサトラリズマブによる治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250127891A1 (https=) |
| EP (1) | EP4466018A4 (https=) |
| JP (1) | JP2025502891A (https=) |
| KR (1) | KR20240145472A (https=) |
| CN (1) | CN118900699A (https=) |
| AU (1) | AU2023209259A1 (https=) |
| CA (1) | CA3243067A1 (https=) |
| IL (1) | IL314213A (https=) |
| MX (1) | MX2024008835A (https=) |
| TW (1) | TW202337495A (https=) |
| WO (1) | WO2023140269A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104761637B (zh) | 2006-03-31 | 2021-10-15 | 中外制药株式会社 | 调控抗体血液动力学的方法 |
| WO2018203545A1 (ja) | 2017-05-02 | 2018-11-08 | 国立研究開発法人国立精神・神経医療研究センター | Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法 |
| WO2019151418A1 (ja) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Ｉｌ－６阻害剤を含有する喘息の治療剤 |
| EP3957324A4 (en) | 2019-04-17 | 2023-02-08 | Hiroshima University | THERAPEUTIC FOR UROLOGICAL ONCOLOGY CHARACTERIZED BY BEING ADMINISTRATED IN COMBINATION WITH IL-6 INHIBITOR AND CCR2 INHIBITOR |
| EP4159236A4 (en) | 2020-05-29 | 2024-08-21 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010003329A (es) | 2007-09-26 | 2010-04-27 | Chugai Pharmaceutical Co Ltd | Anticuerpo anti-receptor de il-6. |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| WO2010065116A2 (en) | 2008-12-02 | 2010-06-10 | The Trustees Of The University Of Pennsylvania | The use of il-27-p28 to antagonize il-6 mediated signaling |
| CA2972393A1 (en) | 2015-02-27 | 2016-09-01 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating il-6-related diseases |
| US20220220210A1 (en) * | 2019-03-29 | 2022-07-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-il-6 receptor antibody-containing inhibitor for inhibiting deterioration of bbb function |
-
2023
- 2023-01-18 KR KR1020247027265A patent/KR20240145472A/ko active Pending
- 2023-01-18 CN CN202380028068.8A patent/CN118900699A/zh active Pending
- 2023-01-18 MX MX2024008835A patent/MX2024008835A/es unknown
- 2023-01-18 JP JP2024543040A patent/JP2025502891A/ja active Pending
- 2023-01-18 US US18/729,273 patent/US20250127891A1/en active Pending
- 2023-01-18 CA CA3243067A patent/CA3243067A1/en active Pending
- 2023-01-18 EP EP23743263.8A patent/EP4466018A4/en active Pending
- 2023-01-18 IL IL314213A patent/IL314213A/en unknown
- 2023-01-18 AU AU2023209259A patent/AU2023209259A1/en active Pending
- 2023-01-18 TW TW112102365A patent/TW202337495A/zh unknown
- 2023-01-18 WO PCT/JP2023/001270 patent/WO2023140269A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025502891A5 (https=) | ||
| Egan et al. | Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine | |
| Perez et al. | Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. | |
| Doorn et al. | High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double‐blind, placebo‐controlled, crossover study | |
| KR101900520B1 (ko) | 복합 조성물 | |
| JP2015187125A5 (https=) | ||
| Present | the efficacy of infliximab in Crohn’s disease—healing of fistulae | |
| US5817699A (en) | Process for the preparation of ketamine ointment | |
| JP2022514194A5 (https=) | ||
| JP2024529434A5 (https=) | ||
| JP2025148449A5 (https=) | ||
| Tumani | Corticosteroids and plasma exchange in multiple sclerosis | |
| Van der Bijl et al. | Rectal ketamine and midazolam for premedication in pediatric dentistry | |
| Rommer et al. | Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions | |
| Vermersch et al. | Mycophenolate mofetil and neurological diseases | |
| Trobe | High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial | |
| EP3701956B1 (en) | Prophylactic and/or therapeutic agent for dementia | |
| US20040147433A1 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
| AU766095B2 (en) | Neuroimmunophilins for selective neuronal radioprotection | |
| Huang et al. | Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study | |
| CN108014337A (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| El Ghazaly et al. | Use of Oral Mini Pulse Dexamethasone in Vitiligo Patients | |
| Klein | Discontinuation of benzodiazepines in patients with anxiety disorders: a focus on alprazolam and alprazolam extended release | |
| Suhongsa et al. | Intravenous Dexamethasone for Preventing Postoperative Nausea and/or Vomiting in Total Abdominal Hysterectomy: A randomized double-blinded, placebo-controlled trial | |
| CN114129722B (zh) | 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途 |